LONDON (Reuters) - Scientists have identified dozens of genes that work differently in the brains of people with schizophrenia, a finding that could narrow the search for new drugs to treat the ...

What causes schizophrenia? This severe mental illness, which affects more than 20 million people worldwide and is characterized by recurrent hallucinations and delusions, often begins to emerge in the ...

In 2015, almost three million adults suffered from schizophrenia, a severe and often incapacitating disorder of the brain characterized by periods of psychosis, hallucinations, delusions, distortions ...

Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated. Schizophrenia onset is typically in adolescence or early adulthood, but its underlying causes are thought ...

It’s common to hear casual descriptions of “schizophrenic” behavior, describing a person oscillating between two extremes. “I ...

Schizophrenia is a severe mental illness that is characterized by disruptions in one’s thought processes, emotional range, behaviors, sensory-perceptual experiences, and adaptive functioning (Tandon ...

Negative perception of schizophrenia is still prevalent in society. However, schizophrenia is only a mental disease that affects the way you think, feel, and behave, and if you receive treatment and ...

Cobenfy (xanomeline-trospium chloride) was approved for the treatment of adults with schizophrenia in 2024. Cobenfy is the first medicine approved for the treatment of schizophrenia that works ...

—A new study suggests that long-term use of antipsychotic medications may be linked to an increased risk of breast cancer among women with schizophrenia. The reasons for this, however, aren’t clear.

A new study finds most of the gap is driven by preventable physical disease.